April 2016<img src="http://feeds.feedburner.com/~r/gim/podcast/current/~4/bmlhkU75HeU" height="1" width="1" alt=""/> <hr> See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for privacy and opt-out information.

April 2016 See acast.com/privacy for privacy and opt-out information.

April 2016 See <a href="https://acast.com/privacy" rel="noopener noreferrer">acast.com/privacy</a> for privacy and opt-out information.

Investigating the lower risk of solid tumors in Down Syndrome

Genetics in Medicine (GIM) is the official journal of the American College of Medical Genetics and Genomics. The journal's mission is to enhance the knowledge, understanding, and practice of medical genetics and genomics through publications in clinical and laboratory genetics and genomics, including ethical, legal, and social issues as well as public health. As genetics and genomics continue to increase in importance and relevance in medical practice, the journal will be an accessible and authoritative resource for the dissemination of medical genetic knowledge to all medical providers through appropriate original research, reviews, commentaries, standards, and guidelines. GIM encourages research that combats racism, includes diverse populations and is written by authors from diverse and underrepresented backgrounds.

Share Investigating the lower risk of solid tumors in Down Syndrome

Sign up to save your podcasts

Investigating the lower risk of solid tumors in Down Syndrome

Investigating the lower risk of solid tumors in Down Syndrome